Presentation TCT 2017 ABSORB PSP: Impact of Technique on Early and Late Outcomes Following Coronary Bioresorbable Scaffold Implantation Presenter: Y. S. Chandrashekhar, David J. Moliterno, Gregg W. Stone October 31, 2017
News Conference News TCT 2017 Long-term Absorb BVS Data Continue to Disappoint Michael O'Riordan October 31, 2017
Presentation TCT 2017 TCT 12: Clinical, Angiographic, and Procedural Correlates of Very Late Absorb Scaffold Thrombosis Multistudy Registry Results Presenter: Yoshinobu Onuma, Joanna J. Wykrzykowska, Stephen G. Ellis October 31, 2017
Presentation TCT 2017 TCT 43: Bioresorbable Scaffold for the Treatment of Calcified Coronary Lesions: IVUS Insights From the ABSORB Japan Trial Presenter: Ulf Landmesser, Bernhard Witzenbichler, Kozo Okada, MD October 31, 2017
Presentation TCT 2017 TCT 9: Absorb Bioresorbable Vascular Scaffold vs Everolimus-Eluting Metallic Stent in Small Vessel Disease -A Propensity Matched Analysis of COMPARE II, RAI, and MAASSTAD-ABSORB Prospective Studies Presenter: Yoshinobu Onuma, Joanna J. Wykrzykowska, Alberto Barioli, MD October 31, 2017
Presentation TCT 2017 ABSORB II: 4-Year Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease Presenter: Robert-Jan van Geuns, Bernard R. Chevalier October 31, 2017
Presentation TCT 2017 Association Between Scaffold Under-Expansion and Late Lumen Loss After Bioresorbable Scaffold Implantation - IVUS and Angiographic Insights From the ABSORB Japan Trial Presenter: Yoshinobu Onuma, Joanna J. Wykrzykowska, Kozo Okada, MD October 31, 2017
Presentation TCT 2017 ABSORB 3-Year Meta-analysis: 3-Year Outcomes of a Bioresorbable Scaffold Compared to a Metallic DES From an Individual Patient Data Meta-analysis of Four Randomized Trials Presenter: David P. Faxon, Joseph A. Hill, Ziad A. Ali October 31, 2017
Presentation TCT 2017 ABSORB IV: 30-Day Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease Presenter: Patrick W. Serruys, Gregg W. Stone October 31, 2017
Presentation TCT 2017 ABSORB III: 3-Year Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease Presenter: Patrick W. Serruys, Stephen G. Ellis October 31, 2017
Presentation TCT 2017 How to Interpret Noninferiority Trials (eg, ABSORB III, EVEREST II, and Others) Presenter: Roxana Mehran, Robert W. Yeh, Sanjay Kaul October 30, 2017
Presentation TCT 2017 Drug Eluting Scaffold With an Absorbable Platform for Primary Lower Extremity Arterial Revascularization DESappear Study Initial Results Presenter: Tony Das, Thomas Zeller October 30, 2017
Presentation TCT 2017 Predicting The Future: Will the ABSORB III/IV Ten-Year Results Change How We Currently View Bioresorbable Vascular Scaffolds? Presenter: C. Michael Gibson, Stephan Windecker, Stephan Achenbach October 30, 2017
Presentation TCT 2017 Lessons from the ABSORB Clinical Program for the Future Presenter: Gary S. Mintz, Seung-Jung Park, Patrick W. Serruys October 29, 2017
News Opinion Fellow Talk My Picks for Fellows Attending TCT 2017 Amit K. Gupta, MBBS, MD October 26, 2017
News Conference News TCT 2017 TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More Shelley Wood October 20, 2017
Presentation Mid- and Long-term Outcome Comparisons of Absorb BVS vs Everolimus-Eluting Stent October 17, 2017
News Daily News Absorb BVS Again Linked to Scaffold Thrombosis at 1 Year and Beyond Michael O'Riordan October 17, 2017
News Daily News Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force Michael O'Riordan October 11, 2017